Literature DB >> 30628993

Neuroimaging Biomarkers at Baseline Predict Electroconvulsive Therapy Overall Clinical Response in Depression: A Systematic Review.

Anna Levy, Simon Taib, Christophe Arbus, Patrice Péran1, Anne Sauvaget, Laurent Schmitt, Antoine Yrondi2.   

Abstract

OBJECTIVE: Major depressive disorder is a frequent and disabling disease and can be treated with antidepressant drugs. When faced with severe or resistant major depressive disorder, however, psychiatrists may resort to electroconvulsive therapy (ECT). Although very effective, the response falls short of 100%. A recent meta-analysis established clinical and biological predictive factors of the response to ECT. We decided to explore neuroimaging biomarkers that could be predictors of the ECT response.
METHODS: We performed a systematic literature review up to January 1, 2018, using a Boolean combination of MeSH terms. We included 19 studies matching our inclusion criteria.
RESULTS: Lower hippocampal, increased amygdala, and subgenual cingulate gyrus volumes were predictive for a better ECT response. Functional magnetic resonance imaging also found that the connectivity between the dorsolateral prefrontal cortex and posterior default-mode network is predictive of increased efficacy. Conversely, deep white matter hyperintensities in basal ganglia and Virchow-Robin spaces, medial temporal atrophy, ratio of left superior frontal to left rostral middle frontal cortical thickness, cingulate isthmus thickness asymmetry, and a wide range of gray and white matter anomalies were predictive for a poorer response.
CONCLUSIONS: Our review addresses the positive or negative predictive value of neuroimaging biomarkers for the ECT response, indispensable in a personalized medicine dynamic. These data could reduce the risk of nonresponders or resistance with earlier effective management. It might also help researchers elucidate the complex pathophysiology of depressive disorders and the functioning of ECT.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30628993     DOI: 10.1097/YCT.0000000000000570

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  4 in total

1.  Development of Neuroimaging-Based Biomarkers in Major Depression.

Authors:  Kyu-Man Han; Byung-Joo Ham; Yong-Ku Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Resting State Functional Connectivity of Brain With Electroconvulsive Therapy in Depression: Meta-Analysis to Understand Its Mechanisms.

Authors:  Preeti Sinha; Himanshu Joshi; Dhruva Ithal
Journal:  Front Hum Neurosci       Date:  2021-01-21       Impact factor: 3.169

3.  Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression.

Authors:  Masashi Ueda; Yuki Konishi; Kohei Sakurai; Atsuko Ikenouchi; Reiji Yoshimura
Journal:  Case Rep Psychiatry       Date:  2020-12-05

4.  Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial.

Authors:  Daniel Keeser; Lucia Bulubas; Frank Padberg; Eva Mezger; Paulo Suen; Priscila V Bueno; Fabio Duran; Geraldo Busatto; Edson Amaro; Isabela M Benseñor; Paulo A Lotufo; Stephan Goerigk; Wagner Gattaz; Andre R Brunoni
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-09-02       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.